We describe the first known case of pneumonia caused by a mucoid Stenotrophomonas maltophilia (Xanthomonas maltophilia) strain in a patient with bronchiectasis. The patient was admitted because of mild hemoptysis and productive cough with infiltrative shadow in the right lower lung field on chest X ray. The clinical symptoms were mild, and treatment with minocycline was effective. 20/min, and small moist rales over the lower area of the right lung. Her chest X-ray film showed an infiltrative shadow in the right lower lobe (Fig. 1) . There was no pleural effusion or cavitation. An electrocardiogram was normal. The diagnosis was right lower lobe pneumonia, and the patient was admitted to our hospital.
Stenotrophomonas maltophilia (Xanthomonas maltophilia) is
the second most commonly isolated pseudomonad from human clinical sources and is generally recognized as an opportunistic pathogen (4) . The name Stenotrophomonas has been proposed by Palleroni and Bradbury (2) (Fig. 1) . There was no pleural effusion or cavitation. An electrocardiogram was normal. The diagnosis was right lower lobe pneumonia, and the patient was admitted to our hospital.
The results of laboratory studies upon admission were as follows: hemoglobin, 13.5 g/dl; hematocrit, 40.5%; leukocyte count, 6.2 x 109/liter, with 53% segmented neutrophils, 31% lymphocytes, 5% monocytes, and 5% eosinophils. The patient was treated empirically with cefpirome sulfate (1 g twice a day) for 3 days, but chest films on day 4 showed little improvement. Sputum cultures at the time of admission and after the 3 days of cefpirome treatment yielded mucoid S. maltophilia. Treatment with minocycline (100 mg twice a day), to which the isolates were susceptible, was initiated on day 4. With this therapy, sputum culture on day 11 yielded no pathogenic bacteria, and no infiltrative shadow was seen on the chest X ray on day 14. She was discharged on day 24 (11 December 1993).
Microbiological studies. Microscopic examination of Gramstained smears of sputum revealed numerous gram-negative rods ingested by polymorphonuclear leukocytes (Fig. 2) . In culture, colonies showed a mucoid appearance (Fig. 3) MIC, 1.56 ,ug/ml; ofloxacin MIC, 1.56 ,ug/ml; piperacillin MIC, 25 jig/ml; ceftazidime MIC, 100 jig/ml; cefazolin MIC, >100 ,ug/ml; cefotiam MIC, >100 jig/ml; ampicillin MIC, >100
,ug/ml; imipenem MIC, >100 jig/ml; erythromycin MIC, >100 jig/ml; clindamycin MIC, >100 jig/ml; fosfomycin MIC, >100 jig/ml; and amikacin MIC, >100 jig/ml. S. maltophilia is increasingly recognized as an opportunistic pathogen in debilitated hosts. Although Sarker and associates (3) reported a primary pulmonary infection caused by S. maltophilia, colonization with S. maltophilia is most common in patients with severe underlying illness, and it can be difficult to distinguish colonization from infection.
In the case of infection described here, the patient was a healthy female without a serious underlying disease. We believe that the present case was primary lung infection caused by mucoid S. maltophilia, because sputum culture on admission exhibited pure and heavy growth of mucoid S. maltophilia, and numerous neutrophils which had phagocytized the organism were observed on microscopic examination of sputum smears. The isolated organism was resistant to a variety of antimicro- bial drugs, but a clinical and bacteriologic cure was achieved with minocycline.
The case described here emphasizes that a mucoid strain of S. maltophilia can be isolated from human clinical sources and may cause pulmonary infection in an immunocompetent host.
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